We produce Active Pharmaceutical Ingredients (APIs) providing integrated full-service capabilities.
Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (APIs) in our network of facilities allows clients full access to integrated services resulting in faster production and delivery timelines, with one of the most extensive track records. We rely on synthetic and biological processes both for Generic and Contract Development and the Manufacturing market, in a full cGMPs environment, following ICH Q7 compliance.
With our structured expertise in chemical synthesis and microbial biomanufacturing, we are one of the leading international players of API and HPAPI production. Our sites are equipped with multi-purpose, dedicated lines where we can produce at different levels of high containment, up to OEB 5.
Our expertise is applied to the production of APIs for treatments used in many key therapeutic areas and for some breakthrough pharmaceutical products. We are leaders, among others, in the production of retinoids, antineoplastic, cardiovascular and metabolic diseases compounds, antibiotics and antivirals.
Headquartered in Rodano (Italy), Olon has 11 manufacturing facilities – 8 located in Italy, 1 in Spain (Murcia), 1 in the USA (Concord, Ohio) and 1 in India (Mahad), all compliant with international requirements, 2 branch offices (Florham Park - USA and Mumbai - India), and 2 trading offices (Hamburg - Germany and Shanghai - China). The facilities of Capua and Settimo Torinese (Italy) are biotech centers, while the one in the USA is fully dedicated to R&D.
Vision and Mission
Each mission comes from a vision. Ours is to challenge and innovate the way to deliver science to improve the health of human beings.We develop creative ideas and pathways for prompt and sustainable solutions in life science industry.
